Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2024-08-21 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
东方证券承销保荐有限公司关于无锡晶海氨基酸股份有限公司募投项目延期的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from the underwriting and sponsorship institution regarding the delay of a fundraising investment project by Wuxi Jinghai Amino Acid Co., Ltd. It includes specifics about the fundraising amount, use of funds, project progress, reasons for delay, impact on the company, and approval procedures. The document references regulatory compliance and internal approvals but does not contain financial statements or quarterly/yearly financial results. It is a regulatory compliance and project update related to fundraising but not a financial report or earnings release. The document length is under 5,000 characters and is a formal opinion/report on a fundraising project delay, which fits best under Capital/Financing Update (CAP).
2024-08-21 Chinese
董事、监事换届公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the change of the company's board of directors and supervisory board members. It details the nomination and election of new directors and supervisors, their shareholdings, qualifications, and the impact of these changes on the company. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements about changes in the company's board or senior management.
2024-08-21 Chinese
关于完成工商变更登记及公司章程备案并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration changes and company charter filing, including obtaining a new business license. It references a prior shareholder meeting decision and provides details about the company's registration and business scope. The document is short (971 characters) and serves as a formal notification of corporate registration updates rather than a financial report or detailed management information. It does not contain financial statements, audit information, or detailed governance reports. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-21 Chinese
投资者关系活动记录表
Investor Presentation Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held on July 11, 2024, including participants, questions asked, and answers given about company operations, production, market strategy, and collaborations. The content is a record of a specific investor relations meeting rather than a formal financial report, earnings release, or regulatory filing. It is not an announcement of a report publication, nor does it contain financial statements or audit information. The document fits best under the category of Investor Presentation (IP), as it provides detailed information for investors focusing on company operations, strategy, and market position during an investor relations event.
2024-07-11 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of stock trading restrictions (解除限售公告) for certain shares of the company Wuxi Jinghai Amino Acid Co., Ltd. It details the number of shares becoming tradable, the shareholders involved, reasons for lifting restrictions, and the updated share capital structure. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share status changes, specifically about stock restriction removal, which fits best under the category of Share Issue/Capital Change (SHA). The document length is short and focused on share capital changes, not a full report or earnings release.
2024-06-30 Chinese
上海市广发律师事务所关于无锡晶海氨基酸股份有限公司2024年第四次临时股东大会的法律意见书
Regulatory Filings
2024-06-24 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.